Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Bostom

Showing results (31-40 of 68) with videos related to

Pageof 7
Sort By:
The American Journal of Clinical Nutrition|March 10, 2001
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohortP F Jacques, A G Bostom, P W Wilson, et al.
Atherosclerosis|July 1, 1995
Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart StudyA G Bostom, P F Jacques, M R Nadeau, et al.
Medicine and Science in Sports and Exercise|April 1, 1991
Lipid and lipoprotein profiles relate to peak aerobic power in spinal cord injured menA G Bostom, M M Toner, W D McArdle, et al.
The Journal of the American Board of Family Practice|September 1, 1996
Family history and premature coronary heart diseaseC B Eaton, A G Bostom, L Yanek, et al.
Transplantation|June 14, 2000
Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patientsA G Bostom, D Shemin, R Y Gohh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipientsA J Beaulieu, R Y Gohh, H Han, et al.
Atherosclerosis|February 1, 1995
Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementationA G Bostom, D Shemin, M R Nadeau, et al.
Journal of the American Society of Nephrology : JASN|January 16, 1999
Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinineA G Bostom, R Y Gohh, L Bausserman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective studyA G Bostom, D Shemin, P Verhoef, et al.
Atherosclerosis|June 8, 2001
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteineI S Weisberg, P F Jacques, J Selhub, et al.
Pageof 7

Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
The American Journal of Clinical Nutrition|March 10, 2001
Determinants of plasma total homocysteine concentration in the Framingham Offspring cohortP F Jacques, A G Bostom, P W Wilson, et al.
Atherosclerosis|July 1, 1995
Post-methionine load hyperhomocysteinemia in persons with normal fasting total plasma homocysteine: initial results from the NHLBI Family Heart StudyA G Bostom, P F Jacques, M R Nadeau, et al.
Medicine and Science in Sports and Exercise|April 1, 1991
Lipid and lipoprotein profiles relate to peak aerobic power in spinal cord injured menA G Bostom, M M Toner, W D McArdle, et al.
The Journal of the American Board of Family Practice|September 1, 1996
Family history and premature coronary heart diseaseC B Eaton, A G Bostom, L Yanek, et al.
Transplantation|June 14, 2000
Treatment of mild hyperhomocysteinemia in renal transplant recipients versus hemodialysis patientsA G Bostom, D Shemin, R Y Gohh, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 11, 1999
Enhanced reduction of fasting total homocysteine levels with supraphysiological versus standard multivitamin dose folic acid supplementation in renal transplant recipientsA J Beaulieu, R Y Gohh, H Han, et al.
Atherosclerosis|February 1, 1995
Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementationA G Bostom, D Shemin, M R Nadeau, et al.
Journal of the American Society of Nephrology : JASN|January 16, 1999
Serum cystatin C as a determinant of fasting total homocysteine levels in renal transplant recipients with a normal serum creatinineA G Bostom, R Y Gohh, L Bausserman, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 31, 1997
Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective studyA G Bostom, D Shemin, P Verhoef, et al.
Atherosclerosis|June 8, 2001
The 1298A-->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteineI S Weisberg, P F Jacques, J Selhub, et al.
Pageof 7